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Background 
This report is a summary of Device-
associated (DA) Module data col-
lected by hospitals participating in the 
National Healthcare Safety Network 
(NHSN) for events occurring from 
January through December 2011 and 
reported to the Centers for Disease 
Control and Prevention (CDC) by 
August 1, 2012.  This report updates 
previously published DA Module data 
from NHSN and provides contempo-
rary comparative rates.1 This report 
complements other NHSN reports, in-
cluding national and state-specific re-
ports of standardized infection ratios 
(SIRs) for select healthcare-associated 
infections (HAIs).2,3,4
NHSN data collection, reporting, and 
analysis are organized into three com-
ponents: Patient Safety, Healthcare 
Personnel Safety, and Biovigilance, 
and use standardized methods and 
definitions in accordance with specific 
module protocols.5,6,7 Institutions may 
use modules singly or simultaneously, 
but once selected, they must be used 
for a minimum of one calendar month 
for the data to be included in CDC 
analyses.  All infections are catego-
rized using standard CDC definitions 
that include laboratory and clinical 
criteria.7 The DA Module may be used 
by facilities other than hospitals, 
including outpatient dialysis centers.  
A report of data from this module 
for outpatient dialysis centers was 
published separately.8 NHSN facilities 
contributing HAI surveillance data to 
this report did so voluntarily, in re-
sponse to state mandatory reporting 
requirements or in compliance with 
the Centers for Medicare and Medic-
aid Services’ (CMS) Hospital Inpatient 
Quality Reporting (IQR) Program. CDC 
aggregated these data into a single 
national database for 2011, consistent 
with the stated purposes of NHSN, 
which were to: 
• Collect data from a sample of 
healthcare facilities in the United 
States to permit valid estima-
tion of the magnitude of adverse 
events among patients and 
healthcare personnel. 
• Collect data from a sample of 
healthcare facilities in the United 
States to permit valid estimation 
of the adherence to practices 
known to be associated with pre-
vention of these adverse events. 
• Analyze and report collected 
data to permit recognition of 
trends. 
• Provide facilities with risk-adjust-
ed metrics that can be used for 
inter-facility comparisons and 
local quality improvement activi-
ties. 
• Assist facilities in developing sur-
veillance and analysis methods 
that permit timely recognition of 
patient and healthcare worker 
safety problems and prompt 
intervention with appropriate 
measures. 
• Conduct collaborative research 
studies with NHSN member fa-
cilities (e.g., describe the epide-
miology of emerging healthcare-
associated infection [HAI] and 
pathogens, assess the impor-
tance of potential risk factors, 
further characterize HAI patho-
gens and their mechanisms of 
resistance, and evaluate alterna-
tive surveillance and prevention 
strategies). 
• Comply with legal requirements 
– including but not limited to 
state or federal laws, regulations, 
or other requirements – for man-
datory reporting of healthcare 
facility-specific adverse event, 
prevention practice adherence, 
and other public health data. 
• Enable healthcare facilities to re-
port HAI and prevention practice 
adherence data via NHSN to the 
U.S. Centers for Medicare and 
Medicaid Services (CMS) in fulfill-
ment of CMS’s quality measure-
ment reporting requirements for 
those data. 
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• Provide state departments of 
health with information that 
identifies the healthcare facilities 
in their state that participate in 
NHSN. 
• Provide to state agencies, at 
their request, facility-specific, 
NHSN patient safety component 
and healthcare personnel safety 
component adverse event and 
prevention practice adherence 
data for surveillance, prevention, 
or mandatory public reporting. 
Patient- and facility-specific data 
reported to CDC are kept confiden-
tial in accordance with sections 304, 
306, and 308(d) of the Public Health 




For reporting to the DA Module, 
healthcare facility personnel respon-
sible for infection prevention and 
patient safety may choose, with con-
sideration of state mandates, federal 
reporting programs, and prevention 
initiatives, to collect data on central 
line-associated primary bloodstream 
infections (CLABSI), ventilator-
associated pneumonias (VAP), or 
urinary catheter-associated urinary 
tract infections (CAUTI) that occur 
in patients staying in a patient care 
location such as a critical or intensive 
care unit (ICU), specialty care area, or 
inpatient ward.   In NHSN, locations 
are further stratified according to 
patient population: adults, children, 
or neonates (in tables, pediatric and 
neonatal locations are so noted).  In 
neonatal intensive care unit (NICU) 
locations (level III or level II/III), infec-
tion preventionists (IPs) collect data 
on central line-associated and um-
bilical catheter-associated BSI or VAP 
that occur in patients in each of five 
birth-weight categories (≤750 g, 751-
1000 g, 1001 - 1500 g, 1501 - 2500 g, 
and >2500 g); data on CAUTI are not 
collected as part of the NHSN proto-
cols in any NICU location. Correspond-
ing location-specific denominator data 
consisting of patient-days and specific 
device-days are also collected by IPs 
or other trained personnel.
In non-NICU locations, the device-days 
consist of the total number of central 
line-days, urinary catheter-days, or 
ventilator-days.  For specialty care 
areas, such as hematology/oncology 
and hematopoietic stem cell trans-
plant locations, central line days are 
split into those with only a permanent 
central line vs. those with temporary 
central lines (with or without a perma-
nent central line). In NICU locations, 
the device-days consist of the total 
number of central line-days and um-
bilical catheter-days, or ventilator days 
for each birth-weight category. 
Data Analysis Methods
Compared to the previous report, 
five new locations – pediatric surgical 
critical care, long term care rehabilita-
tion unit, long term acute care critical 
care, long term acute care ward, and 
inpatient rehabilitation facility– had 
sufficient data to be included in this 
report.1
Locations were further stratified by 
unit bed size and/or major teaching 
status to determine if pooled mean 
rates, medians, and empirical distribu-
tions significantly differed between 
two groups for all DA infections; if dif-
ferences were present, the strata were 
retained for reporting. Comparisons of 
pooled mean rates were performed us-
ing Poisson regression.  These compari-
sons could be influenced by potential 
outlier rates from locations with 
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disproportionately large denominators. 
Therefore, greater weight was given 
to the results of nonparametric tests 
comparing the medians for location 
shift and empirical distributions for 
assessing differences across the range 
of reported rates.  These nonparamet-
ric comparisons by definition require 
no validity assumptions and provide 
test results that are not subject to the 
potential weighting influence of high 
or low rates with large denominators. 
Comparisons of the median and per-
centile distribution were made if there 
were at least 50 locations contributing 
to one or more strata and at least 20 
locations contributing to the percentile 
distribution in both strata. 
Existing strata were retained for adult 
combined medical/surgical ICUs, med-
ical ICUs, and surgical ICUs. The data 
for adult combined medical/surgical 
ICUs were split by hospital type and 
unit bedsize, resulting in three groups: 
“major teaching,” “all others” with 
unit bedsize ≤15 beds, and “all others” 
with unit bedsize >15.   The data for 
adult medical ICUs and adult surgical 
ICUs were split into two groups by 
teaching status.  Facilities self-identi-
fied teaching status through an annual 
facility survey. Major teaching status 
was defined as a hospital that is an 
important part of the medical school 
teaching program in which the major-
ity of medical students rotate through 
multiple clinical services. Adult bone 
marrow transplant and adult hema-
tology/oncology locations were also 
evaluated to assess importance of 
status as an oncology hospital, but dif-
ferences were not significant and no 
new strata were retained.
Device utilization (DU) was calculated 
as a ratio of device days to patient 
days for each location type.  As such, 
the DU of a location is one measure 
of the use of invasive devices and 
constitutes an extrinsic risk factor for 
healthcare-associated infection.9 DU 
may also serve as a marker for sever-
ity of illness of patients (i.e. more 
severely ill patients are more likely 
to require an invasive device) which 
is another reflection of the intrinsic 
susceptibility to infection. 
Data from at least 5 different report-
ing units of a given location type were 
used to determine pooled mean DA 
infection rates and DU ratios. Percen-
tile distributions were determined if 
there were data from at least 20 dif-
ferent locations, excluding rates or DU 
ratios for locations that did not report 
at least 50 device-days or patient-
days. Because of these requirements, 
the number of locations contributing 
data may vary among the tables. 
Results   
In 2011, 3,854 hospitals reported at 
least one month of DA denominator 
data for some patient cohorts under 
surveillance. These 3,854 hospitals 
were located in 53 states, territories, 
and the District of Columbia and were 
predominantly general acute care hos-
pitals (Table 1); approximately two-
thirds were smaller hospitals of 200 
beds or less (65%), and only 10.9% 
were categorized as major teaching 
facilities (Table 2).  Additionally, 60% 
of the hospitals included in this report 
are located in states with a mandate 
for reporting at least one type of DA 
infection to NHSN. Where data vol-
ume was sufficient for this report, we 
tabulated DA infection rates and DU 
ratios for January through December 
2011 (Tables 3-10).  Data on the spe-
cific criteria used to report DA infec-
tions are provided in Tables 11-18. 
Tables 3-6 update and augment 
previously published DA rates and DU 
ratios by type of non-NICU locations.1 
Beginning in 2012, long term acute 
care (LTAC) units were re-categorized 
by acuity level into critical care or 
ward designations; therefore, in order 
to align with current data reporting 
methods in this location type, LTAC 
data in this report have been catego-
rized in the same manner.  Addition-
ally, data from inpatient rehabilitation 
facilities (IRFs), as defined by the 
Centers for Medicare and Medicaid 
Services (CMS), have been reported 
separately from non-IRF rehabilitation 
wards within acute care hospitals.
Tables 7-10 update and augment the 
previously published, DA rates and 
DU ratios by birth-weight category for 
NICU locations.1 Beginning in January 
2012, CLABSI data in NICU locations are 
no longer collected according to central 
line type (i.e., central line and umbili-
cal catheter); in order to align with the 
current reporting of these data, CLABSI 
rates and DU ratios for NICUs are not 
stratified by line type in this report. 
Tables 11-18 provide data on select 
attributes of the DA infections for 
each location.  For example, Tables 11, 
12, 15 and 16 show the frequency and 
percent distribution of the specific 
sites of CLABSI and the criteria used 
for identifying these infections.  Note 
that for these tables, criteria 2 and 3 
have been combined.  
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Discussion
This report summarizes the HAI data 
reported to the DA module of NHSN 
during 2011. The data in this report 
continue to be restricted to a single 
year for several reasons. First, NHSN 
saw continued growth in participation 
due to state mandates and federal re-
porting programs and because of this, 
there were sufficient data reported 
in 2011 to support the analysis of a 
single year of data (e.g., consider-
able data contributing to the pooled 
means, most location types with >20 
locations reporting), thus obviating 
the need to combine data with previ-
ous years. Second, analyzing one year 
of data removes the need to assess 
the influence of any large increase 
of new reporters in a single year of a 
multiyear summary measure. Finally, 
by restricting data to a single year, 
changes in HAI rates are more ap-
parent and can highlight continued 
prevention efforts in different patient 
care areas. This strategy also fulfills 
the need for more timely publication 
of comparative rates. 
The characteristics of hospitals report-
ing to NHSN are similar to those seen 
in the last published report, although 
this report demonstrates a slight 
increase in contribution from smaller 
hospitals.1  Based on the number of 
facilities reporting, overall contribu-
tion to the device-associated mod-
ule increased by 56% from the last 
report.1 This increase in reporting is 
largely attributed to hospitals’ partici-
pation in the CMS Hospital Inpatient 
Quality Reporting Program which 
requires participants to use NHSN as 
the tool to report CLABSI data from all 
adult, pediatric, and neonatal ICUs be-
ginning in January 2011. While much 
of this growth impacted the volume of 
CLABSI reporting in ICUs, there is an 
indication of increased participation  
in non-ICU locations for CLABSI report-
ing, as well as reporting for other HAIs 
in this module. 
Extensive analyses of the impact of 
hospital type on all DA infection rates 
were performed for select ICU loca-
tions. Hospital type continues to be a 
significant factor for all three DA infec-
tion rates and percentile distributions 
in medical ICUs and surgical ICUs. Ad-
ditionally, hospital type and bed size 
both continue to be significant factors 
in DA infection rates for medical/surgi-
cal ICUs. Note that while the CLABSI 
rates between unit bedsize strata in 
medical/surgical “all other” ICUs are 
equal (Table 3), the percentile distri-
butions were shown to be significantly 
different as a result of nonparametric 
statistical tests. Therefore, this strati-
fication by unit bedsize in “all other” 
medical/surgical ICUs was retained.  
Adult bone marrow transplant and 
adult hematology/oncology locations 
were not further stratified by hospital 
type (i.e., oncology hospital vs. all oth-
er acute care hospitals) as the results 
of the statistical tests indicated that 
the differences in the strata were not 
statistically significant. Beginning in 
2013, oncology hospitals will be pro-
vided with fourteen oncology-specific 
CDC locations with which to identify 
for device-associated infection surveil-
lance. As the volume of these data 
become sufficient, future analyses will 
continue to assess any potential differ-
ences in this specialized population. 
Tables 11-18 were included to aid the 
reader in interpreting the DA infec-
tion rates data.  One important use 
of these data is to better understand 
the distribution of DA infections by 
type of reporting criterion nationally.  
For example, approximately 82% of 
the CLABSIs from adult and pediatric 
ICU and inpatient wards were identi-
fied using the least subjective crite-
rion (1) which attributes the CLABSI 
to a recognized pathogen; however, 
for NICUs, approximately two-thirds 
used this criterion, resulting in a 
greater percentage of CLABSIs in this 
population that were identified with 
common commensals. Similarly, the 
specific type of ventilator-associated 
pneumonia (VAP) most frequently re-
ported, regardless of location, was the 
clinical criterion (PNU1) which relies 
on the somewhat subjective interpre-
tations of clinical findings.  
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As more and diverse types of facilities 
participate in NHSN either voluntarily 
or by mandate, the need for careful 
scrutiny of the data increases. We will 
continue to assess how the chang-
ing composition of facilities and the 
changing proportion of data contribut-
ed by various types of facilities impact 
the rates and their distributions so 
that the best possible risk-adjusted 
comparative data may be provided in 
future reports.
To improve the reliability of data 
reported to NHSN, several protocol 
changes are set to occur in January 
2013. The majority of these changes 
are with respect to timing and imple-
mentation of two-day rules to clarify 
infections that are healthcare-associ-
ated, association of device use to HAI, 
and attribution of HAI to an inpatient 
location after transfer or to a hospital 
after discharge. In addition, NHSN will 
add criteria for mucosal barrier injury 
laboratory-confirmed bloodstream 
infections. Finally, the VAP definition 
will no longer apply to adult patients 
(i.e., ≥ 18 years of age) and this defini-
tion will be replaced by ventilator-
associated events (VAEs).10 We will 
carefully assess the potential impact 
of these changes on HAI incidence as 
these data are reported. 
For those who do not report to NHSN 
but would like to use these data for 
comparison, the information must 
first be collected from your hospital in 
accordance with the methods de-
scribed for NHSN.5,6,7 Refer to Appen-
dices A and B for further instructions.  
Appendix A discusses the calculation 
of infection rates and DU ratios for the 
DA Module.  Appendix B gives a step-
by-step method for interpretation of 
percentiles of infection rates or DU 
ratios.  Although a high rate or ratio 
(>90th percentile) does not necessar-
ily define a problem, it does suggest 
an area for further investigation.  Simi-
larly, a low rate or ratio (<10th percen-
tile) may be the result of inadequate 
infection detection.
Facilities should use the data in this 
report and their own data to guide 
local prevention strategies and other 
quality improvement efforts to reduce 
the occurrence of infections as much 
as possible. The data presented in this 
report can be used to prioritize pre-
vention efforts in those patient care 
areas that are shown to have the high-
est incidence of DA infections and/
or high device utilization. Facilities 
may also wish to set targets based on 
the percentile distributions provided 
in this report in an effort to strive for 
lower rates and greater prevention 
success.
The authors are indebted to the NHSN participants 
for their ongoing efforts to monitor infections and 
improve patient safety.  We also gratefully acknowl-
edge our colleagues in the Division of Healthcare 
Quality Promotion who tirelessly support this unique 
public health network.
The findings and conclusions of the report are those 
of the authors and do not necessarily represent the 
official position of the Centers for Disease Control 
and Prevention.
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Table 1. NHSN hospitals contributing data used in this report
Hospital type N (%)
Children’s 62 (1.6)
General, including acute, trauma, and teaching 3,426 (88.9)







Veterans Affairs 16 (0.4)
Women’s 5 (0.1)
Women’s and Children’s 10 (0.3)
Total 3,854 (10 0.0)
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 <= 200 201-500 501-1000 > 1000
N (%) N (%) N (%) N (%)
Major teaching 104 (2.7) 185 (4.8) 123 (3.2) 9 (0.2) 421 (10.9)
Graduate teaching 125 (3.2) 153 (4.0) 35 (0.9) 3 (0.1) 316 (8.2)
Limited teaching 193 (5.0) 157 (4.1) 30 (0.8) 1 (0.0) 381 (9.9)
Nonteaching 2,085 (54.1) 594 (15.4) 55 (1.4) 2 (0.0) 2736 (71.0)
Total 2,807 (65.0) 1,089 (28.3) 243 (6.3) 15 (0.4) 3,854 (100)
Major: Hospital is an important part of the teaching program of a medical school and the majority of medical students rotate 
through multiple clinical services.
Graduate: Hospital is used by the medical school for graduate training programs only; i.e., residency and/or fellowships.
Limited: Hospital is used in the medical school’s teaching program only to a limited extent.
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Table 3. Pooled means and key percentiles of the distribution of laboratory-confirmed central line-
associated BSI rates and central line utilization ratios, by type of location, DA module, 2011
Central line-associated BSI rate* Percentile

















































Burn 71 (70) 301 80,426 3.7 0.0 1.2 2.8 5.8 8.4
Medical 
     -Major teaching 198 (197) 703 563,577 1.2 0.0 0.4 1.1 1.8 2.9
Medical 
     -All other 476 (451) 769 675,620 1.1 0.0 0.0 0.5 1.6 2.9
Medical cardiac 423 (415) 673 605,187 1.1 0.0 0.0 0.8 1.7 2.8
Medical/surgical 
     -Major teaching 304 (300) 937 693,570 1.4 0.0 0.0 1.1 1.9 3.1
Medical/surgical 
     -All other ≤15 beds 1,860 (1669) 1,246 1,416,501 0.9 0.0 0.0 0.0 1.1 2.5
Medical/surgical 
     -All other > 15 beds 800 (795) 1,959 2,174,055 0.9 0.0 0.2 0.7 1.4 2.2
Neurologic 50 76 76,580 1.0 0.0 0.0 0.7 1.6 2.2
Neurosurgical 166 309 300,009 1.0 0.0 0.0 0.8 1.6 2.3
Pediatric cardiothoracic 38 180 110,127 1.6 0.0 1.1 1.6 2.1 2.7
Pediatric medical 36 (29) 34 24,777 1.4 0.0 0.0 0.0 1.6 2.7
Pediatric medical/surgical 300 (281) 717 403,728 1.8 0.0 0.0 1.3 2.6 4.1
Pediatric surgical 6 (5) 3 3,473 0.9
Prenatal 8 (3) 0 330 0.0
Respiratory 10 8 14,524 0.6
Surgical 
     -Major teaching 161 514 435,010 1.2 0.0 0.2 1.0 1.9 3.1
Surgical 
     -All other 218 (214) 429 419,669 1.0 0.0 0.0 0.8 1.6 2.8
Surgical cardiothoracic 457 (456) 762 934,275 0.8 0.0 0.0 0.5 1.1 1.9
Trauma 140 511 328,713 1.6 0.0 0.5 1.3 2.4 3.3
Step-Down Units
Adult step-down (post-critical care) 502 (493) 588 607,681 1.0 0.0 0.0 0.0 1.2 2.5
Step-down NICU (level II) 42 (20) 8 5,366 1.5 0.0 0.0 0.0 0.0 1.0
Pediatric step-down (post-critical care) 11 19 9,430 2.0
Inpatient Wards
Acute stroke 17 10 12,742 0.8
Antenatal 11 (4) 1 1,988 0.5
Behavioral health/psychiatry 94 (29) 4 7,253 0.6 0.0 0.0 0.0 0.0 0.2
Burn 15 5 6,451 0.8
Genitourinary 13 19 20,684 0.9
Geronotology 9 (8) 7 7,050 1.0
Gynecology 47 (26) 7 13,137 0.5 0.0 0.0 0.0 0.0 0.7
Jail 17 (16) 11 9,875 1.1
Labor and delivery 48 (7) 0 950 0.0
Labor, delivery, recovery, postpartum suite 89 (14) 1 3,223 0.3
Medical 770 (735) 908 963,923 0.9 0.0 0.0 0.3 1.5 2.9
Medical/surgical 1,892 (1,756) 1,606 1,844,384 0.9 0.0 0.0 0.0 1.2 2.4
Neurologic 49 (48) 44 56,575 0.8 0.0 0.0 0.0 1.1 2.5
Neurosurgical 57 (56) 47 59,918 0.8 0.0 0.0 0.0 0.8 2.0
Orthopedic 242 (213) 98 158,131 0.6 0.0 0.0 0.0 0.8 1.6
Orthopedic trauma 15 32 18,907 1.7
Pediatric medical 47 (42) 62 50,476 1.2 0.0 0.0 0.0 1.6 2.9
Pediatric medical/surgical 241 (185) 197 170,549 1.2 0.0 0.0 0.0 1.6 3.5
Pediatric rehabilitation|| 8 7 6,737 1.0
Pediatric surgical 11 21 16,215 1.3
Postpartum 128 (11) 1 2,648 0.4
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Pulmonary 31 52 55,230 0.9 0.0 0.0 0.7 1.4 2.3
Rehabilitation - non-IRF|| 71 (65) 10 32,617 0.3 0.0 0.0 0.0 0.0 1.4
Surgical 444 (421) 410 506,033 0.8 0.0 0.0 0.0 1.1 2.3
Telemetry 225 (219) 188 219,853 0.9 0.0 0.0 0.0 1.4 3.0
Vascular Surgery 23 14 35,321 0.4 0.0 0.0 0.0 0.7 1.2
Well-Baby Nursery 16 (5) 2 640 3.1
Inpatient Long Term Care§
Chronic care 15 (13) 5 11,338 0.4
Ventilator dependent unit 6 19 10,806 1.8
Long-Term Acute Care Hospitals‡
Adult critical care 18 76 38,805 2.0
Adult Ward 229 (227) 1,431 1,205,212 1.2 0.0 0.3 1.0 1.8 2.9
Inpatient Rehabilitation Facilities¶
Adult rehabilitation units - Freestanding 77 (73) 23 51,943 0.4 0.0 0.0 0.0 0.4 1.7
Adult rehabilitation units - Within hospital 167 (162) 43 77,585 0.6 0.0 0.0 0.0 0.0 2.5
Central line utilization ratio** Percentile















































Burn 71 (70) 80,426 172,984 0.46 0.22 0.35 0.45 0.57 0.78
Medical 
     -Major teaching 198 563,577 913,585 0.62 0.42 0.54 0.62 0.70 0.78
Medical 
     -All other 476 (471) 675,620 1,487,717 0.45 0.13 0.25 0.43 0.58 0.71
Medical cardiac 423 (422) 605,187 1,427,575 0.42 0.19 0.29 0.42 0.56 0.68
Medical/surgical 
     -Major teaching 304 (303) 693,570 1,291,401 0.54 0.26 0.42 0.55 0.66 0.74
Medical/surgical 
     -All other ≤15 beds 1,860 (1,822) 1,416,501 4,069,614 0.35 0.10 0.18 0.33 0.50 0.63
Medical/surgical 
     -All other > 15 beds 800 2,174,055 4,420,558 0.49 0.30 0.40 0.51 0.61 0.71
Neurologic 50 76,580 152,036 0.50 0.23 0.37 0.48 0.59 0.70
Neurosurgical 166 300,009 683,553 0.44 0.28 0.36 0.45 0.54 0.62
Pediatric cardiothoracic 38 110,127 156,466 0.70 0.48 0.61 0.73 0.86 0.91
Pediatric medical 36 (34) 24,777 65,428 0.38 0.07 0.15 0.25 0.44 0.53
Pediatric medical/surgical 300 (295) 403,728 866,685 0.47 0.14 0.25 0.39 0.53 0.61
Pediatric surgical 6 3,473 8,516 0.41
Prenatal 8 330 7,408 0.04
Respiratory 10 14,524 30,748 0.47
Surgical 
     -Major teaching 161 435,010 699,783 0.62 0.41 0.52 0.60 0.72 0.80
Surgical 
     -All other 218 (215) 419,669 746,500 0.56 0.37 0.46 0.56 0.68 0.77
Surgical cardiothoracic 457 934,275 1,425,711 0.66 0.40 0.50 0.67 0.81 0.91
Trauma 140 328,713 601,489 0.55 0.36 0.45 0.57 0.65 0.72
Step-Down Units
Adult step-down (post-critical care) 502 (499) 607,681 2,949,613 0.21 0.08 0.12 0.18 0.29 0.41
Step-down NICU (level II) 42 (41) 5,366 52,925 0.10 0.02 0.04 0.07 0.13 0.17
Pediatric step-down (post-critical care) 11 9,430 37,574 0.25
Inpatient Wards
Acute stroke 17 12,742 93,295 0.14
Antenatal 11 1,988 42,651 0.05
Behavioral health/psychiatry 94 7,253 228,529 0.03 0.01 0.01 0.02 0.03 0.05
Burn 15 6,451 35,906 0.18
Genitourinary 13 20,684 85,847 0.24
Geronotology 9 7,050 57,819 0.12
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Gynecology 47 13,137 123,917 0.11 0.01 0.01 0.04 0.13 0.29
Jail 17 9,875 55,242 0.18
Labor and delivery 48 (45) 950 44,530 0.02 0.00 0.01 0.01 0.03 0.11
Labor, delivery, recovery, postpartum suite 89 (88) 3,223 121,634 0.03 0.00 0.01 0.02 0.03 0.04
Medical 770 (766) 963,923 5,421,265 0.18 0.06 0.10 0.15 0.22 0.32
Medical/surgical 1,892 (1,888) 1,844,384 12,356,081 0.15 0.04 0.07 0.12 0.18 0.25
Neurologic 49 56,575 366,417 0.15 0.07 0.11 0.13 0.19 0.25
Neurosurgical 57 59,918 401,591 0.15 0.07 0.09 0.15 0.20 0.25
Orthopedic 242 (241) 158,131 1,478,952 0.11 0.02 0.05 0.09 0.13 0.18
Orthopedic trauma 15 18,907 114,147 0.17
Pediatric medical 47 (46) 50,476 212,541 0.24 0.03 0.09 0.18 0.31 0.37
Pediatric medical/surgical 241 (239) 170,549 923,148 0.18 0.03 0.04 0.11 0.23 0.32
Pediatric rehabilitation|| 8 6,737 32,984 0.20
Pediatric surgical 11 16,215 64,153 0.25
Postpartum 128 2,648 258,807 0.01 0.00 0.00 0.01 0.01 0.03
Pulmonary 31 55,230 233,443 0.24 0.10 0.15 0.21 0.31 0.45
Rehabilitation - non-IRF|| 71 32,617 302,440 0.11 0.04 0.06 0.08 0.14 0.25
Surgical 444 (440) 506,033 2,955,338 0.17 0.05 0.09 0.15 0.21 0.27
Telemetry 225 (223) 219,853 1,646,413 0.13 0.06 0.09 0.13 0.17 0.22
Vascular Surgery 23 35,321 158,729 0.22 0.09 0.14 0.19 0.31 0.45
Well-Baby Nursery 16 640 15,265 0.04
Inpatient Long Term Care§
Chronic care 15 (13) 11,338 67,078 0.17
Ventilator dependent unit 6 10,806 33,390 0.32
Long-Term Acute Care Hospitals‡
Adult critical care 18 38,805 69,278 0.56
Adult Ward 229 1,205,212 1,901,569 0.63 0.43 0.54 0.69 0.79 0.87
Inpatient Rehabilitation Facilities¶
Adult rehabilitation units - Freestanding 77 51,943 694,684 0.07 0.03 0.04 0.06 0.09 0.13
Adult rehabilitation units - Within hospital 167 77,585 761,155 0.10 0.04 0.06 0.08 0.13 0.18
CLABSI, central line-associated bloodstream infection; NICU, neonatal intensive care unit.
* Number of CLABSI                 x 1000 
Number of central line-days
** Number of central line-days 
Number of patient-days
BSI, bloodstream infection; CLABSI, central line-associated BSI.
† The number in parentheses is the number of locations meeting minimum requirements for percentile distributions (i.e., ≥  50 device days for 
rate distributions, ≥ 50 patient days for device utilization ratios) if less than total number of locations. If this number < 20, percentile distribu-
tions are not calculated.
‡ Includes free-standing long-term acute care hospitals and long-term acute care locations within the general acute care hospital setting.
§ Includes inpatient long term care locations within the general acute care hospital setting. 
|| Includes only in-hospital rehabilitation wards that are not defined as inpatient rehabilitation facilities (IRF) per the CMS Inpatient Rehabilita-
tion Facility Quality Reporting Program.
¶ Includes free-standing inpatient rehabilitation facilities and inpatient rehabilitation facilities within the acute care hospital setting, as defined 
by the CMS Inpatient Rehabilitation Facility Quality Reporting Program.
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Table 4. Pooled means and key percentiles of the distribution of laboratory-confirmed permanent 
and temporary central line-associated BSI rates and central line utilization ratios, by type 
of speciality care area/oncology location, DA module, 2011
Permanent Central line-associated BSI rate* Percentile






















































Hematopoietic stem cell transplant 49 (48) 285 117,264 2.4 0.0 0.9 1.9 3.8 5.3
General hematology/oncology 163 (162) 400 295,200 1.4 0.0 0.0 1.0 1.9 3.1
Pediatric hematopoietic stem cell transplant 13 67 30,530 2.2
Pediatric general hematology/oncology 40 212 127,444 1.7 0.0 0.6 1.6 2.2 3.3
Solid organ transplant 19 (15) 27 16,448 1.6
Temporary Central line-associated BSI rate** Percentile





















































Hematopoietic stem cell transplant 48 (47) 204 87,507 2.3 0.0 0.9 1.8 3.2 4.7
General hematology/oncology 170 (169) 475 243,144 2.0 0.0 0.0 1.4 2.8 4.7
Pediatric hematopoietic stem cell transplant 11 (8) 11 5,193 2.1
Pediatric general hematology/oncology 41 (39) 84 37,815 2.2 0.0 0.0 1.0 3.3 4.8
Solid organ transplant 19 58 34,735 1.7
Permanent Central line utilization ratio# Percentile



















































Hematopoietic stem cell transplant 49 117,264 227,282 0.52 0.16 0.28 0.50 0.67 0.81
General hematology/oncology 163 295,200 984,067 0.30 0.12 0.18 0.28 0.40 0.53
Pediatric hematopoietic stem cell transplant 13 30,530 39,571 0.77
Pediatric general hematology/oncology 40 127,444 206,284 0.62 0.34 0.44 0.59 0.79 0.84
Solid organ transplant 19 (18) 16,448 101,176 0.16
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Temporary Central line utilization ratio## Percentile 


















































Hematopoietic stem cell transplant 48 87,507 210,124 0.42 0.10 0.28 0.40 0.62 0.74
General hematology/oncology 170 243,144 1,045,450 0.23 0.08 0.14 0.21 0.32 0.44
Pediatric hematopoietic stem cell transplant 11 5,193 29,099 0.18
Pediatric general hematology/oncology 41 37,815 198,657 0.19 0.05 0.07 0.13 0.31 0.41
Solid organ transplant 19 34,735 111,538 0.31
BSI, bloodstream infection; PCLABSI, permanent central line-associated BSI; TCLABSI, temporary central line-associated BSI
* Number of PCLABSI     x 1000 
Number of permanent central line-days
** Number of TCLABSI                              x 1000 
Number of temporary central line-days
# Number of permanent central line-days 
Number of patient-days
## Number of temporary central line-days 
Number of patient-days
† The number in parentheses is the number of locations meeting minimum requirements for percentile distributions (i.e., ≥  50 device days for 
rate distributions, ≥ 50 patient days for device utilization ratios) if less than total number of locations. If this number is < 20, percentile distribu-
tions are not calculated.
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Table 5. Pooled means and key percentiles of the distribution of urinary catheter-associated UTI 
rates and urinary catheter utilization ratios, by type of location, DA module, 2011
Urinary catheter-associated UTI rate* Percentile



















































Burn 38 148 36,222 4.1 0.0 0.0 2.8 5.2 8.6
Medical 
     -Major teaching 99 739 287,880 2.6 0.0 0.7 2.0 3.4 5.0
Medical 
     -All other 212 (202) 552 350,509 1.6 0.0 0.0 0.7 2.1 3.5
Medical cardiac 211 (207) 596 301,884 2.0 0.0 0.0 1.3 2.9 5.0
Medical/surgical 
     -Major teaching 146 (145) 827 381,416 2.2 0.0 0.1 1.6 2.8 4.5
Medical/surgical 
     -All other ≤15 beds 793 (748) 921 750,795 1.2 0.0 0.0 0.0 1.6 3.5
Medical/surgical 
     -All other > 15 beds 405 1,685 1,181,301 1.4 0.0 0.4 1.1 2.1 3.1
Neurologic 21 116 34,422 3.4 0.0 1.5 2.5 4.9 6.6
Neurosurgical 74 812 181,986 4.5 0.0 1.8 3.8 5.5 8.1
Pediatric cardiothoracic 10 (9) 12 8,764 1.4
Pediatric medical 11 (10) 5 1,736 2.9
Pediatric medical/surgical 129 (110) 217 70,607 3.1 0.0 0.0 0.8 3.5 8.0
Prenatal 6 (2) 1 781 1.3
Respiratory 6 11 7,869 1.4
Surgical 
     -Major teaching 75 552 213,845 2.6 0.4 1.2 2.1 3.5 5.1
Surgical 
     -All other 103 (102) 366 185,967 2.0 0.0 0.1 1.3 2.5 4.4
Surgical cardiothoracic 216 (213) 560 356,842 1.6 0.0 0.0 1.0 2.2 3.4
Trauma 75 776 230,687 3.4 0.2 1.3 2.5 4.1 6.0
Specialty Care Areas/Oncology
Hematopoietic stem cell transplant 31 (29) 28 15,218 1.8 0.0 0.0 0.0 2.8 4.6
General hematology/oncology 93 (91) 162 76,670 2.1 0.0 0.5 1.9 3.1 4.7
Pediatric general hematology/oncology 10 (7) 4 1,213 3.3
Solid organ transplant 10 21 12,370 1.7
Step-Down Units
Adult step-down (post-critical care) 318 (313) 764 439,142 1.7 0.0 0.0 1.3 2.7 4.5
Pediatric step-down (post-critical care) 7 (5) 3 709 4.2
Inpatient Wards
Acute stroke 11 23 13,825 1.7
Antenatal 7 0 971 0.0
Behavioral health/psychiatry 91 (31) 19 7,517 2.5 0.0 0.0 0.0 0.2 8.1
Burn 10 (9) 11 2,278 4.8
Genitourinary 7 16 8,166 2.0
Gerontology 9 (8) 11 6,052 1.8
Gynecology 41 (36) 17 25,605 0.7 0.0 0.0 0.0 0.0 2.2
Jail 7 (4) 4 2,344 1.7
Labor and delivery 53 (39) 5 22,350 0.2 0.0 0.0 0.0 0.0 0.1
Labor, delivery, recovery, postpartum suite 118 (100) 16 37,717 0.4 0.0 0.0 0.0 0.0 0.0
Medical 577 (566) 979 646,918 1.5 0.0 0.0 1.0 2.4 3.9
Medical/Surgical 1,345 (1,292) 1,979 1,484,664 1.3 0.0 0.0 0.8 2.0 3.5
Neurologic 34 95 44,538 2.1 0.0 0.5 1.5 3.8 5.2
Neurosurgical 35 126 51,830 2.4 0.0 0.5 1.5 3.8 6.1
Orthopedic 169 (166) 308 233,542 1.3 0.0 0.0 0.8 2.0 3.8
Orthopedic trauma 10 32 17,818 1.8
Pediatric medical/surgical 141 (73) 38 27,035 1.4 0.0 0.0 0.0 2.0 5.1
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Pediatric medical 27 (11) 6 3,703 1.6
Pediatric surgical 7 (6) 9 6,293 1.4
Postpartum 140 (133) 32 68,027 0.5 0.0 0.0 0.0 0.0 1.7
Pulmonary 22 67 34,677 1.9 0.0 0.3 1.1 3.0 3.8
Rehabilitation - non-IRF|| 43 (40) 45 14,210 3.2 0.0 0.0 0.0 4.3 10.1
Surgical 313 (308) 660 437,413 1.5 0.0 0.0 1.0 2.2 4.3
Telemetry 90 (88) 132 114,507 1.2 0.0 0.0 0.8 1.9 3.8
Vascular surgery 10 15 10,396 1.4
Well-baby nursery 8 (1) 0 126 0.0
Inpatient Long Term Care§
Chronic care 16 (5) 12 7,945 1.5
Long-term care rehabilitation unit 8 18 2,550 7.1
Long-Term Acute Care Hospitals‡
Adult critical care 6 17 4,777 3.6
Adult Ward 166 (165) 1,407 652,175 2.2 0.0 0.9 1.8 3.1 4.8
Inpatient Rehabilitation Facilities¶
Adult rehabilitation units - Freestanding 82 (81) 164 54,732 3.0 0.0 0.0 1.4 3.9 6.5
Adult rehabilitation units - Within hospital 138 (126) 147 47,869 3.1 0.0 0.0 1.1 5.2 9.0
Urinary catheter utilization ratio** Percentile

















































Burn 38 36,222 72,139 0.50 0.34 0.38 0.45 0.64 0.76
Medical 
     -Major teaching 99 287,880 410,123 0.70 0.56 0.65 0.74 0.80 0.85
Medical 
     -All other 212 (210) 350,509 570,682 0.61 0.33 0.53 0.68 0.78 0.85
Medical cardiac 211 (210) 301,884 597,741 0.51 0.25 0.38 0.53 0.66 0.74
Medical/surgical 
     -Major teaching 146 (145) 381,416 551,855 0.69 0.49 0.62 0.74 0.80 0.83
Medical/surgical 
     -All other ≤15 beds 793 (766) 750,795 1,399,138 0.54 0.31 0.46 0.61 0.73 0.81
Medical/surgical 
     -All other > 15 beds 405 1,181,301 1,776,793 0.66 0.49 0.60 0.71 0.78 0.84
Neurologic 21 34,422 48,549 0.71 0.32 0.56 0.73 0.82 0.84
Neurosurgical 74 181,986 261,682 0.70 0.54 0.61 0.71 0.79 0.85
Pediatric cardiothoracic 10 8,764 45,281 0.19
Pediatric medical 11 1,736 14,045 0.12
Pediatric medical/surgical 129 (126) 70,607 311,974 0.23 0.07 0.12 0.20 0.26 0.32
Prenatal 6 781 7,926 0.10
Respiratory 6 7,869 17,388 0.45
Surgical 
     -Major teaching 75 213,845 282,221 0.76 0.58 0.70 0.77 0.83 0.88
Surgical 
     -All other 103 (102) 185,967 261,357 0.71 0.45 0.64 0.75 0.81 0.89
Surgical cardiothoracic 216 (215) 356,842 530,154 0.67 0.41 0.55 0.69 0.82 0.88
Trauma 75 230,687 292,809 0.79 0.62 0.74 0.80 0.87 0.94
Specialty Care Areas/Oncology
Hematopoietic stem cell transplant 31 15,218 135,776 0.11 0.04 0.05 0.07 0.15 0.24
General hematology/oncology 93 (92) 76,670 492,732 0.16 0.07 0.09 0.15 0.21 0.30
Pediatric general hematology/oncology 10 1,213 49,541 0.02
Solid organ transplant 10 12,370 61,782 0.20
Step-Down Units
Adult step-down (post-critical care) 318 439,142 1,708,256 0.26 0.12 0.17 0.25 0.37 0.52
Pediatric step-down (post-critical care) 7 709 21,427 0.03
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Inpatient Wards
Acute stroke 11 13,825 40,059 0.35
Antenatal 7 971 9,257 0.10
Behavioral health/psychiatry 91 7,517 216,343 0.03 0.00 0.01 0.02 0.04 0.07
Burn 10 2,278 15,692 0.15
Genitourinary 7 8,166 48,061 0.17
Gerontology 9 6,052 48,732 0.12
Gynecology 41 25,605 124,166 0.21 0.07 0.12 0.20 0.29 0.47
Jail 7 2,344 24,249 0.10
Labor and delivery 53 22,350 101,221 0.22 0.02 0.06 0.13 0.20 0.44
Labor, delivery, recovery, postpartum suite 118 (116) 37,717 243,461 0.15 0.06 0.10 0.13 0.19 0.28
Medical 577 (574) 646,918 3,758,665 0.17 0.08 0.12 0.17 0.22 0.30
Medical/Surgical 1,345 (1,335) 1,484,664 7,712,951 0.19 0.10 0.13 0.18 0.24 0.31
Neurologic 34 44,538 213,695 0.21 0.09 0.15 0.20 0.24 0.36
Neurosurgical 35 51,830 229,333 0.23 0.10 0.17 0.21 0.32 0.50
Orthopedic 169 233,542 869,225 0.27 0.13 0.20 0.27 0.34 0.44
Orthopedic trauma 10 17,818 76,451 0.23
Pediatric medical/surgical 141 (138) 27,035 382,338 0.07 0.01 0.01 0.04 0.08 0.15
Pediatric medical 27 (26) 3,703 81,712 0.05 0.01 0.01 0.01 0.03 0.16
Pediatric surgical 7 6,293 39,998 0.16
Postpartum 140 68,027 519,219 0.13 0.03 0.08 0.13 0.19 0.29
Pulmonary 22 34,677 154,604 0.22 0.09 0.16 0.19 0.23 0.50
Rehabilitation - non-IRF|| 43 14,210 166,012 0.09 0.03 0.05 0.07 0.13 0.16
Surgical 313 (311) 437,413 1,875,890 0.23 0.12 0.17 0.23 0.30 0.40
Telemetry 90 (89) 114,507 548,651 0.21 0.10 0.15 0.21 0.25 0.31
Vascular surgery 10 10,396 65,192 0.16
Well-baby nursery 8 (7) 126 2,149 0.06
Inpatient Long Term Care§
Chronic care 16 (13) 7,945 41,541 0.19
Long-term care rehabilitation unit 8 2,550 38,741 0.07
Long-Term Acute Care Hospitals‡
Adult critical care 6 4,777 11,806 0.40
Adult Ward 166 652,175 1,258,801 0.52 0.31 0.43 0.51 0.62 0.71
Inpatient Rehabilitation Facilities¶
Adult rehabilitation units - Freestanding 82 54,732 700,414 0.08 0.03 0.05 0.07 0.09 0.13
Adult rehabilitation units - Within hospital 138 47,869 521,238 0.09 0.03 0.05 0.08 0.12 0.16
CLABSI, central line-associated bloodstream infection; NICU, neonatal intensive care unit.
* Number of CLABSI                 x 1000 
Number of central line-days
** Number of central line-days 
Number of patient-days
BSI, bloodstream infection; CLABSI, central line-associated BSI.
† The number in parentheses is the number of locations meeting minimum requirements for percentile distributions (i.e., ≥  50 device days for 
rate distributions, ≥ 50 patient days for device utilization ratios) if less than total number of locations. If this number < 20, percentile distribu-
tions are not calculated.
‡ Includes free-standing long-term acute care hospitals and long-term acute care locations within the general acute care hospital setting.
§ Includes inpatient long term care locations within the general acute care hospital setting. 
|| Includes only in-hospital rehabilitation wards that are not defined as inpatient rehabilitation facilities (IRF) per the CMS Inpatient Rehabilita-
tion Facility Quality Reporting Program.
¶ Includes free-standing inpatient rehabilitation facilities and inpatient rehabilitation facilities within the acute care hospital setting, as defined 
by the CMS Inpatient Rehabilitation Facility Quality Reporting Program.
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Table 6. Pooled means and key percentiles of the distribution of ventilator-associated PNEU rates 
and ventilator utilization ratios, by type of location, DA module, 2011
Ventilator-associated PNEU rate* Percentile















































Burn 31 (30) 88 17,844 4.9 0.0 0.0 4.2 8.8 12.5
Medical 
     -Major teaching 89 188 174,412 1.1 0.0 0.0 0.7 1.8 3.0
Medical 
     -All other 156 (141) 152 156,191 1.0 0.0 0.0 0.0 1.0 3.0
Medical cardiac 161 (152) 138 128,369 1.1 0.0 0.0 0.0 1.3 3.8
Medical/surgical 
     -Major teaching 123 (118) 461 215,214 2.1 0.0 0.0 1.0 2.3 5.4
Medical/surgical 
     -All other ≤15 beds 597 (482) 296 267,272 1.1 0.0 0.0 0.0 1.2 4.3
Medical/surgical 
     -All other >15 beds 317 (315) 527 509,492 1.0 0.0 0.0 0.6 1.6 2.8
Neurologic 19 64 17,656 3.6
Neurosurgical 66 (65) 161 70,894 2.3 0.0 0.0 0.7 3.0 5.9
Pediatric cardiothoracic 15 12 28,756 0.4
Pediatric medical 11 6 7,385 0.8
Pediatric medical/surgical 121 (112) 146 135,585 1.1 0.0 0.0 0.0 1.4 3.2
Respiratory 6 0 3,984 0.0
Surgical 
     -Major teaching 70 290 122,472 2.4 0.0 0.6 1.7 3.5 6.4
Surgical 
     -All other 83 (81) 165 82,363 2.0 0.0 0.0 0.1 2.8 4.7
Surgical cardiothoracic 168 (164) 268 154,234 1.7 0.0 0.0 0.6 2.4 5.3
Trauma 56 499 106,857 4.7 0.0 0.9 3.1 7.5 13.5
Specialty Care Areas/Oncology
Hematopoietic stem cell transplant 5 (4) 0 1,118 0.0
Step-Down Units
Adult step-down (post-critical care) 73 (59) 41 38,572 1.1 0.0 0.0 0.0 1.0 3.7
Step-down NICU (level II) 6 (0) 0 93 0.0
Inpatient Wards
Medical 34 (21) 1 8,316 0.1 0.0 0.0 0.0 0.0 0.0
Medical/surgical 53 (32) 17 23,349 0.7 0.0 0.0 0.0 0.7 2.3
Neurosurgical 5 1 3,178 0.3
Pediatric medical 6 (5) 0 2,707 0.0
Pediatric medical/surgical 10 (8) 0 2,609 0.0
Pulmonary 7(5) 6 5,840 1.0
Telemetry 5 (3) 1 1,245 0.8
Long-Term Acute Care Hospitals‡
Adult critical care 6 2 4,314 0.5
Adult ward 144 (139) 114 249,330 0.5 0.0 0.0 0.0 0.6 1.2
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Ventilator utilization ratio** Percentile















































Burn 31 17,844 66,570 0.27 0.10 0.16 0.24 0.30 0.42
Medical 
     -Major teaching 89 174,412 381,557 0.46 0.29 0.38 0.47 0.57 0.65
Medical 
     -All other 156 (153) 156,191 444,893 0.35 0.09 0.19 0.32 0.47 0.56
Medical cardiac 161 (160) 128,369 461,148 0.28 0.10 0.17 0.25 0.35 0.43
Medical/surgical 
     -Major teaching 123 (122) 215,214 522,459 0.41 0.16 0.26 0.39 0.49 0.59
Medical/surgical 
     -All other ≤15 beds 597 (582) 267,272 1,118,363 0.24 0.05 0.11 0.21 0.32 0.44
Medical/surgical 
     -All other >15 beds 317 (316) 509,492 1,473,581 0.35 0.18 0.26 0.35 0.44 0.51
Neurologic 19 17,656 48,822 0.36
Neurosurgical 66 70,894 236,554 0.30 0.14 0.24 0.29 0.38 0.45
Pediatric cardiothoracic 15 28,756 64,406 0.45
Pediatric medical 11 7,385 22,346 0.33
Pediatric medical/surgical 121 135,585 339,407 0.40 0.13 0.20 0.34 0.44 0.52
Respiratory 6 3,984 11,366 0.35
Surgical 
     -Major teaching 70 122,472 292,517 0.42 0.20 0.30 0.40 0.50 0.57
Surgical 
     -All other 83 (82) 82,363 238,048 0.35 0.15 0.23 0.31 0.45 0.52
Surgical cardiothoracic 168 154,234 462,733 0.33 0.16 0.22 0.31 0.41 0.51
Trauma 56 106,857 225,654 0.47 0.36 0.42 0.48 0.55 0.64
Specialty Care Areas/Oncology
Hematopoietic stem cell transplant 5 1,118 19,480 0.06
Step-Down Units
Adult step-down (post-critical care) 73 38,572 346,418 0.11 0.01 0.03 0.08 0.13 0.31
Step-down NICU (level II) 6 93 4,706 0.02
Inpatient Wards
Medical 34 8,316 168,127 0.05 0.00 0.01 0.02 0.04 0.07
Medical/surgical 53 23,349 319,638 0.07 0.00 0.01 0.03 0.07 0.19
Neurosurgical 5 3,178 28,557 0.11
Pediatric medical 6 2,707 30,620 0.09
Pediatric medical/surgical 10 2,609 52,868 0.05
Pulmonary 7 5,840 35,269 0.17
Telemetry 5 1,245 20,685 0.06
Long-Term Acute Care Hospitals‡
Adult critical care 6 4,314 11,806 0.37
Adult ward 144 249,330 1,129,832 0.22 0.07 0.12 0.20 0.29 0.40
VAP, ventilator-associated pneumonia.
* Number of VAP                        x 1000 
Number of ventilator-days
** Number of ventilator-days 
Number of patient-days
† The number in parentheses is the number of locations meeting minimum requirements for percentile distributions (i.e., ≥  50 device days for 
rate distributions, ≥ 50 patient days for device utilization ratios) if less than total number of locations. If this number < 20, percentile distribu-
tions are not calculated.
‡ Includes free-standing long-term acute care hospitals and long-term acute care locations within the general acute care hospital setting.
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Table 7. Pooled means and key percentiles of the distribution of central line-associated BSI rates 
and central line utilization ratios for level III NICUs, DA module, 2011 















































< 750 grams 385 (342) 500 196,659 2.5 0.0 0.0 1.6 4.3 7.8
751-1000 grams 405 (351) 339 168,938 2.0 0.0 0.0 0.3 3.2 6.3
1001-1500 grams 412 (368) 244 186,099 1.3 0.0 0.0 0.0 1.9 4.5
1501-2500 grams 408 (348) 150 163,339 0.9 0.0 0.0 0.0 0.7 2.7
> 2500 grams 413 (331) 154 181,091 0.9 0.0 0.0 0.0 0.3 2.1














































< 750 grams 385 (351) 196,659 452,309 0.43 0.29 0.37 0.45 0.57 0.72
751-1000 grams 405 (370) 168,938 456,349 0.37 0.23 0.30 0.38 0.47 0.65
1001-1500 grams 412 (405) 186,099 654,187 0.28 0.14 0.20 0.27 0.38 0.52
1501-2500 grams 408 (405) 163,339 885,095 0.18 0.05 0.08 0.14 0.22 0.43
> 2500 grams 413 (406) 181,091 713,246 0.25 0.06 0.10 0.17 0.30 0.45
CLABSI, central line-associated bloodstream infection; NICU, neonatal intensive care unit.
* Number of CLABSI                 x 1000 
Number of central line-days
** Number of central line-days 
Number of patient-days
† The number in parentheses is the number of locations meeting minimum requirements for percentile distributions (i.e., ≥  50 device days for 
rate distributions, ≥ 50 patient days for device utilization ratios) if less than total number of locations. If this number < 20, percentile distribu-
tions are not calculated.
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Table 8. Pooled means and key percentiles of the distribution of central line-associated BSI rates 
and central line utilization ratios for level II/III NICUs, DA module, 2011















































< 750 grams 364 (265) 295 110,172 2.7 0.0 0.0 0.0 4.4 8.6
751-1000 grams 412 (296) 193 101,645 1.9 0.0 0.0 0.0 3.2 6.9
1001-1500 grams 486 (363) 147 126,819 1.2 0.0 0.0 0.0 1.5 4.4
1501-2500 grams 520 (355) 87 117,530 0.7 0.0 0.0 0.0 0.0 2.3
> 2500 grams 525 (315) 77 109,730 0.7 0.0 0.0 0.0 0.0 1.9














































< 750 grams 364 (288) 110,172 266,479 0.41 0.28 0.35 0.48 0.63 0.78
751-1000 grams 412 (335) 101,645 264,904 0.38 0.22 0.30 0.39 0.51 0.65
1001-1500 grams 486 (438) 126,819 460,014 0.28 0.12 0.18 0.27 0.37 0.51
1501-2500 grams 520 (495) 117,530 740,279 0.16 0.04 0.07 0.12 0.19 0.32
> 2500 grams 525 (494) 109,730 555,599 0.20 0.05 0.08 0.12 0.22 0.32
CLABSI, central line-associated bloodstream infection; NICU, neonatal intensive care unit.
* Number of CLABSI                 x 1000 
Number of central line-days
** Number of central line-days 
Number of patient-days
†    The number in parentheses is the number of locations meeting minimum requirements for percentile distributions (i.e., ≥  50 device days for 
rate distributions, ≥ 50 patient days for device utilization ratios) if less than total number of locations. If this number < 20, percentile distribu-
tions are not calculated.
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Table 9.    Pooled means and key percentiles of the distribution of ventilator-associated PNEU rates 
and ventilator utilization ratios for level III NICUs, DA module, 2011













































< 750 grams 127 (112) 89 57,133 1.6 0.0 0.0 0.0 2.2 6.9
751-1000 grams 125 (104) 47 32,501 1.4 0.0 0.0 0.0 0.9 4.4
1001-1500 grams 130 (88) 20 19,974 1.0 0.0 0.0 0.0 0.0 2.9
1501-2500 grams 129 (69) 9 17,250 0.5 0.0 0.0 0.0 0.0 0.1
> 2500 grams 128 (72) 6 29,102 0.2 0.0 0.0 0.0 0.0 0.0
Ventilator utilization ratio** Percentile












































< 750 grams 127 (118) 57,133 147,932 0.39 0.22 0.30 0.43 0.55 0.66
751-1000 grams 125 (118) 32,501 145,520 0.22 0.07 0.13 0.22 0.34 0.48
1001-1500 grams 130 (127) 19,974 185,367 0.11 0.02 0.05 0.08 0.16 0.28
1501-2500 grams 129 (128) 17,250 253,259 0.07 0.01 0.02 0.04 0.09 0.19
> 2500 grams 128 29,102 230,077 0.13 0.02 0.03 0.07 0.14 0.23
VAP, ventilator-associated pneumonia; NICU, neonatal intensive care unit.
* Number of VAP                 x 1000 
Number of ventilator-days
** Number of ventilator-days 
Number of patient-days
†    The number in parentheses is the number of locations meeting minimum requirements for percentile distributions (i.e., ≥  50 device days for 
rate distributions, ≥ 50 patient days for device utilization ratios) if less than total number of locations. If this number < 20, percentile distribu-
tions are not calculated.
22
Table 10. Pooled means and key percentiles of the distribution of ventilator-associated PNEU 
rates and ventilator utilization ratios for level II/III NICUs, DA module, 2011













































< 750 grams 99 (69) 49 27,190 1.8 0.0 0.0 0.0 2.8 5.9
751-1000 grams 105 (66) 21 14,685 1.4 0.0 0.0 0.0 0.0 9.7
1001-1500 grams 118 (52) 7 8,464 0.8 0.0 0.0 0.0 0.0 1.5
1501-2500 grams 131 (43) 7 8,590 0.8 0.0 0.0 0.0 0.0 3.8
> 2500 grams 136 (44) 2 10,737 0.2 0.0 0.0 0.0 0.0 0.0













































< 750 grams 99 (80) 27,190 73,463 0.37 0.21 0.27 0.39 0.53 0.65
751-1000 grams 105 (87) 14,685 67,793 0.22 0.09 0.14 0.22 0.33 0.45
1001-1500 grams 118 (101) 8,464 102,660 0.08 0.02 0.04 0.07 0.12 0.20
1501-2500 grams 131 (127) 8,590 167,465 0.05 0.01 0.02 0.03 0.05 0.11
> 2500 grams 136 (125) 10,737 123,770 0.09 0.02 0.03 0.04 0.08 0.15
* Number of VAP                 x 1000 
Number of ventilator-days
** Number of ventilator-days 
Number of patient-days
†    The number in parentheses is the number of locations meeting minimum requirements for percentile distributions (i.e., ≥  50 device days 
for rate distributions, ≥ 50 patient days for device utilization ratios) if less than total number of locations. If this number < 20, percentile 
distributions are not calculated.
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Criterion 1  n (%) Criterion 2/3  n (%) Total
Acute Care Hospitals
Critical Care
Burn 281 93.4% 20 6.6% 301
Medical 
     -Major teaching 605 86.1% 98 13.9% 703
Medical 
     -All other 620 80.6% 149 19.4% 769
Medical cardiac 542 80.5% 131 19.5% 673
Medical/surgical 
     -Major teaching 783 83.6% 154 16.4% 937
Medical/surgical 
     -All other ≤15 beds 1,003 80.5% 243 19.5% 1,246
Medical/surgical 
     -All other > 15 beds 1,540 78.6% 419 21.4% 1,959
Neurologic 55 72.4% 21 27.6% 76
Neurosurgical 220 71.2% 89 28.8% 309
Pediatric cardiothoracic 143 79.4% 37 20.6% 180
Pediatric medical 32 94.1% 2 5.9% 34
Pediatric medical/surgical 567 79.1% 150 20.9% 717
Pediatric surgical 3 100.0% 0 0.0% 3
Respiratory 8 100.0% 0 0.0% 8
Surgical 
     -Major teaching 406 79.0% 108 21.0% 514
Surgical 
     -All other 360 83.9% 69 16.1% 429
Surgical cardiothoracic 641 84.1% 121 15.9% 762
Trauma 437 85.5% 74 14.5% 511
Step-Down Units
Adult step-down (post-critical care) 486 82.7% 102 17.3% 588
Step-down NICU (level II) 4 50.0% 4 50.0% 8
Pediatric step-down (post-critical care) 17 89.5% 2 10.5% 19
Inpatient Wards
Acute stroke 8 80.0% 2 20.0% 10
Antenatal 0 0.0% 1 100.0% 1
Behavioral health/psychiatry 4 100.0% 0 0.0% 4
Burn 5 100.0% 0 0.0% 5
Genitourinary 14 73.7% 5 26.3% 19
Geronotology 7 100.0% 0 0.0% 7
Gynecology 6 85.7% 1 14.3% 7
Jail 10 90.9% 1 9.1% 11
Labor, delivery, recovery, postpartum suite 1 100.0% 0 0.0% 1
Medical 764 84.1% 144 15.9% 908
Medical/surgical 1,347 83.9% 259 16.1% 1,606
Neurologic 38 86.4% 6 13.6% 44
Neurosurgical 37 78.7% 10 21.3% 47
Orthopedic 72 73.5% 26 26.5% 98
Orthopedic trauma 27 84.4% 5 15.6% 32
Pediatric medical 54 87.1% 8 12.9% 62
Pediatric medical/surgical 160 81.2% 37 18.8% 197
Pediatric rehabilitation - non-IRF|| 7 100.0% 7
Pediatric surgical 20 95.2% 1 4.8% 21
Postpartum 1 100.0% 0 0.0% 1
Pulmonary 45 86.5% 7 13.5% 52
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Rehabilitation - non-IRF|| 9 90.0% 1 10.0% 10
Surgical 335 81.7% 75 18.3% 410
Telemetry 163 86.7% 25 13.3% 188
Vascular Surgery 13 92.9% 1 7.1% 14
Well-Baby Nursery 1 50.0% 1 50.0% 2
Inpatient Long Term Care§
Chronic care 5 100.0% 0 0.0% 5
Ventilator dependent unit 16 84.2% 3 15.8% 19
Long-Term Acute Care Hospitals‡
Adult critical care 68 89.5% 8 10.5% 76
Adult Ward 1,204 84.1% 227 15.9% 1,431
Inpatient Rehabilitation Facilities¶
Adult rehabilitation units - Freestanding 21 91.3% 2 8.7% 23
Adult rehabilitation units - Within hospital 38 88.4% 5 11.6% 43
Total 13,253 82.5% 2,854 17.8% 16,064
BSI, bloodstream infection; LCBI, laboratory-confirmed BSI.7
‡ Includes free-standing long-term acute care hospitals and long-term acute care locations within the general acute care hospital 
setting.
§ Includes inpatient long term care locations within the general acute care hospital setting. 
|| Includes only in-hospital rehabilitation wards that are not defined as inpatient rehabilitation facilities (IRF) per the CMS Inpa-
tient Rehabilitation Facility Quality Reporting Program.
¶ Includes free-standing inpatient rehabilitation facilities and inpatient rehabilitation facilities within the acute care hospital set-
ting, as defined by the CMS Inpatient Rehabilitation Facility Quality Reporting Program.
25
Table 12.    Distribution of criteria for permanent and temporary central line-
associated  laboratory-confirmed BSI by location, 2011
Type of location
LCBI
TotalCriterion 1 n (%) Criterion 2/3 n (%)
Permanent Central Line
Hematopoietic stem cell transplant 219 76.8% 66 23.2% 285
General hematology/oncology 307 76.8% 93 23.3% 400
Pediatric hematopoietic stem cell transplant 55 82.1% 12 17.9% 67
Pediatric general hematology/oncology 175 82.5% 37 17.5% 212
Solid organ transplant 24 88.9% 3 11.1% 27
Total 780 78.7% 211 21.3% 991
Temporary Central Line
Hematopoietic stem cell transplant 164 80.4% 40 19.6% 204
General hematology/oncology 387 81.5% 88 18.5% 475
Pediatric hematopoietic stem cell transplant 9 81.8% 2 18.2% 11
Pediatric general hematology/oncology 69 82.1% 15 17.9% 84
Solid organ transplant 47 81.0% 11 19.0% 58
Total 676 81.3% 156 18.8% 832
BSI, bloodstream infection; LCBI, laboratory-confirmed BSI.7
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Table 13. Distribution of specific sites of urinary catheter-associated UTI by location, 2011
Type of Location SUTI n (%) ABUTI n (%) Total
Acute Care Hospitals
Critical Care
Burn 147 99.3% 1 0.7% 148
Medical 
     -Major teaching 728 98.5% 11 1.5% 739
Medical 
     -All other 541 98.0% 11 2.0% 552
Medical cardiac 588 98.7% 8 1.3% 596
Medical/surgical 
     -Major teaching 816 98.7% 11 1.3% 827
Medical/surgical 
     -All other ≤15 beds 901 97.8% 20 2.2% 921
Medical/surgical 
     -All other > 15 beds 1,652 98.0% 33 2.0% 1,685
Neurologic 115 99.1% 1 0.9% 116
Neurosurgical 810 99.8% 2 0.2% 812
Pediatric cardiothoracic 12 100.0% 12
Pediatric medical 5 100.0% 5
Pediatric medical/surgical 212 97.7% 5 2.3% 217
Pediatric 1 100.0% 1
Respiratory 11 100.0% 11
Surgical 
     -Major teaching 548 99.3% 4 0.7% 552
Surgical 
     -All other 356 97.3% 10 2.7% 366
Surgical cardiothoracic 551 98.4% 9 1.6% 560
Trauma 771 99.4% 5 0.6% 776
Specialty Care Areas/Oncology
Hematopoietic stem cell transplant 28 100.0% 28
General hematology/oncology 159 98.1% 3 1.9% 162
Pediatric general hematology/oncology 4 100.0% 4
Solid organ transplant 21 100.0% 21
Step-Down Units
Adult step-down (post-critical care) 749 98.0% 15 2.0% 764
Pediatric step-down (post-critical care) 3 100.0% 3
Inpatient Wards
Acute stroke 22 95.7% 1 4.3% 23
Behavioral health/psychiatry 19 100.0% 19
Burn 11 100.0% 11
Genitourinary 16 100.0% 16
Geronotology 11 100.0% 11
Gynecology 17 100.0% 17
Jail 4 100.0% 4
Labor and delivery 5 100.0% 5
Labor, delivery, recovery, postpartum suite 15 93.8% 1 6.3% 16
Medical 961 98.2% 18 1.8% 979
Medical/surgical 1,959 99.0% 20 1.0% 1,979
Neurologic 95 100.0% 95
Neurosurgical 126 100.0% 126
Orthopedic 306 99.4% 2 0.6% 308
Orthopedic trauma 32 100.0% 32
Pediatric medical/surgical 38 100.0% 38
Pediatric medical 6 100.0% 6
Pediatric surgical 9 100.0% 9
Postpartum 32 100.0% 32
Pulmonary 64 95.5% 3 4.5% 67
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Rehabilitation - non-IRF|| 44 97.8% 1 2.2% 45
Surgical 654 99.1% 6 0.9% 660
Telemetry 131 99.2% 1 0.8% 132
Vascular Surgery 15 100.0% 15
Inpatient Long Term Care§
Chronic care 12 100.0% 12
Long-term care rehabilitation unit 18 100.0% 18
Long-Term Acute Care Hospitals‡
Adult critical care 17 100.0% 17
Adult Ward 1,391 98.9% 15 1.1% 1,406
Inpatient Rehabilitation Facilities¶
Adult rehabilitation units - Freestanding 164 100.0% 164
Adult rehabilitation units - Within hospital 143 97.3% 4 2.7% 147
Total 16,066 98.7% 217 1.3% 16,283
UTI, urinary tract infection; SUTI, symptomatic UTI; ABUTI, asymptomatic bacteremic UTI.7
‡   Includes free-standing long-term acute care hospitals and long-term acute care locations within the general acute care hospital 
setting.
§ Includes inpatient long term care locations within the general acute care hospital setting. 
|| Includes only in-hospital rehabilitation wards that are not defined as inpatient rehabilitation facilities (IRF) per the CMS Inpatient 
Rehabilitation Facility Quality Reporting Program.
¶ Includes free-standing inpatient rehabilitation facilities and inpatient rehabilitation facilities within the acute care hospital setting, 
as defined by the CMS Inpatient Rehabilitation Facility Quality Reporting Program.
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Table 14. Distribution of specific sites of ventilator-associated pneumonia by location, 2011
Type of location PNU1 n (%) PNU2 n (%) PNU3 n (%) Total
Acute Care Hospitals
Critical Care Units
Burn 37 42.0% 51 58.0% 88
Medical 
     -Major teaching 117 62.2% 68 36.2% 3 1.6% 188
Medical 
     -All other 124 81.6% 28 18.4% 152
Medical cardiac 76 55.1% 62 44.9% 138
Medical/surgical 
     -Major teaching 213 46.2% 245 53.1% 3 0.7% 461
Medical/surgical 
     -All other ≤15 beds 214 72.3% 75 25.3% 7 2.4% 296
Medical/surgical 
     -All other >15 beds 309 58.6% 204 38.7% 14 2.7% 527
Neurologic 19 29.7% 45 70.3% 64
Neurosurgical 79 49.1% 81 50.3% 1 0.6% 161
Pediatric cardiothoracic 9 75.0% 3 25.0% 12
Pediatric medical 6 100.0% 6
Pediatric medical/surgical 111 76.0% 34 23.3% 1 0.7% 146
Surgical 
     -Major teaching 142 49.0% 138 47.6% 10 3.4% 290
Surgical 
     -All other 80 48.5% 82 49.7% 3 1.8% 165
Surgical cardiothoracic 154 57.5% 107 39.9% 7 2.6% 268
Trauma 244 48.9% 251 50.3% 4 0.8% 499
Step-Down Units
Adult step-down (post-critical care) 35 85.4% 6 14.6% 41
Inpatient Wards
Medical 1 100.0% 1
Medical/surgical 5 29.4% 12 70.6% 17
Neurosurgical 1 100.0% 1
Pulmonary 6 100.0% 6
Telemetry 1 100.0% 1
Long Term Acute Care*
Adult critical care 1 50.0% 1 50.0% 2
Adult ward 82 71.9% 32 28.1% 114
Total 2,060 56.5% 1,530 42.0% 54 1.5% 3,644
PNU1, clinically defined pneumonia; PNU2, pneumonia with specific laboratory findings; PNU3, pneumonia in immunocompromised patients.7
* Includes free-standing long-term acute care hospitals and long-term acute care locations within the general acute care hospital setting.
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Table 15. Distribution of specific sites and criteria for central line-associated 
laboratory-confirmed BSI among Level III NICUs by birthweight, 2011
Birth-weight category
LCBI
TotalCriterion 1 n (%) Criterion 2/3 n (%)
≤ 750 grams 346 69.2% 154 30.8% 500
751-1000 grams 216 63.7% 123 36.3% 339
1001-1500 grams 156 63.9% 88 36.1% 244
1501-2500 grams 106 70.7% 44 29.3% 150
> 2500 grams 118 76.6% 36 23.4% 154
Total 942 67.9% 445 32.1% 1387
BSI, bloodstream infection; LCBI, laboratory-confirmed BSI.7
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Table 16. Distribution of specific sites and criteria for central line-associated 
laboratory-confirmed BSI among Level II/III NICUs by birthweight, 2011
Birth-weight category
LCBI
TotalCriterion 1 n (%) Criterion 2/3 n (%)
≤ 750 grams 194 65.8% 101 34.2% 295
751-1000 grams 119 61.7% 74 38.3% 193
1001-1500 grams 86 58.5% 61 41.5% 147
1501-2500 grams 55 63.2% 32 36.8% 87
> 2500 grams 50 64.9% 27 35.1% 77
Total 504 63.1% 295 36.9% 799
BSI, bloodstream infection; LCBI, laboratory-confirmed BSI.7
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Table 17. Distribution of specific sites of ventilator-associated pneumonia among Level III NICUs 
by birthweight, 2011
Birth-weight category PNU1 n (%) PNU2 n (%) PNU3 n (%) Total
≤ 750 grams 62 69.7% 26 29.2% 1 1.1% 89
751-1000 grams 29 61.7% 17 36.2% 1 2.1% 47
1001-1500 grams 15 75.0% 5 25.0% 20
1501-2500 grams 6 66.7% 3 33.3% 9
> 2500 grams 6 100.0% 6
Total 118 69.0% 51 29.8% 2 1.2% 171
PNU1, clinically defined pneumonia; PNU2, pneumonia with specific laboratory findings; PNU3, pneumonia in immunocompromised patients.7
32
Table 18. Distribution of specific sites of ventilator-associated pneumonia among Level II/III NICUs 
by birthweight, 2011
Birth-weight category PNU1 n (%) PNU2 n (%) PNU3 n (%) Total
≤ 750 grams 37 75.5% 7 14.3% 5 10.2% 49
751-1000 grams 14 66.7% 5 23.8% 2 9.5% 21
1001-1500 grams 6 85.7% 1 14.3% 7
1501-2500 grams 7 100.0% 7
> 2500 grams 2 100.0% 2
Total 66 76.7% 13 15.1% 7 8.1% 86
PNU1, clinically defined pneumonia; PNU2, pneumonia with specific laboratory findings; PNU3, pneumonia in immunocompromised patients.7
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Appendix A.  
How to calculate a device-associated infection rate and device utilization ratio with 
Device-associated Module data  
Calculation of Device-associated Infection Rate
Step 1: Decide upon the time period for your analysis.  It may be a month, a quarter, 6 months, a year, or some other period.
Step 2: Select the patient population for analysis, e.g., the type of location or a birthweight category in a NICU.
Step 3: Select the infections to be included in the numerator.  They must be site-specific and must have occurred in the se-
lected patient population.  Their date of onset must be during the selected time period.
Step 4: Determine the number of device-days which is used as the denominator of the rate.  Device-days are the total 
number of days of exposure to the device (central line, umbilical catheter, ventilator, or urinary catheter) by all of the 
patients in the selected population during the selected time period.
Example: Five patients on the first day of the month had one or more central lines in place; five on day 2; two on day 
3; five on day 4; three on day 5; four on day 6; and four on day 7.  Adding the number of patients with central lines 
on days 1 through 7, we would have 5+5+2+5+3+4+4=28 central line-days for the first week.  If we continued for the 
entire month, the number of central line-days for the month is simply the sum of the daily counts.
Step 5: Calculate the device-associated infection rate (per 1000 device-days) using the following formula:
Device-associated Infection Rate =  
Number of device-associated infections for an infection site x 1000 
                          Number of device-days
Example: Central line-associated BSI rate per 1000 central line-days =  
Number of central line-associated BSI x 1000 
          Number of central line-days
Calculation of Device Utilization (DU) Ratio
Steps 1,2,4: Same as device-associated infection rates plus determine the number of patient-days which is used as the 
denominator of the DU ratio.  Patient-days are the total number of days that patients are in the location during 
the selected time period.
Example: Ten patients were in the unit on the first day of the month; 12 on day 2; 11 on day 3; 13 on day 4; 10 
on day 5; 6 on day 6; and 10 on day 7; and so on.  If we counted the patients in the unit from days 1 through 7, 
we would add 10 + 12 + 11 + 13 + 10 + 6 + 10 for a total of 72 patient-days for the first week of the month.  If we 
continued for the entire month, the number of patient-days for the month is simply the sum of the daily counts.
Step 5:  Calculate the DU ratio with the following formula:
DU Ratio = 
Number of device-days   
Number of patient-days
With the number of device-days and patient-days from the examples above,  
DU = 28/72 = 0.39 or 39% of patient-days were also central line-days for the first week of the month. 
Step 6: Examine the size of the denominator for your hospital’s rate or ratio.  Rates or ratios may not be good estimates of 
the “true” rate or ratio for your hospital if the denominator is small, i.e., <50 device-days or patient-days.  
Step 7: Compare your hospital’s location-specific rates or ratios with those found in the tables of this report.  Refer to Appen-
dix B for interpretation of the percentiles of the rates/ratios.  
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Appendix B.   
Interpretation of percentiles of infection rates or device utilization ratios
Step 1: Evaluate the rate (ratio) you have calculated for your hospital and confirm that the variables in the rate (both numer-
ator and denominator) are identical to the rates (ratios) in the table. 
Step 2: Examine the percentiles in each of the tables and look for the 50th percentile (or median).  At the 50th percentile, 
50% of the hospitals have lower rates (ratios) than the median and 50% have higher rates (ratios).  
Step 3: Determine if your hospital’s rate (ratio) is above or below this median.    
Determining whether your hospital’s rate or ratio is a HIGH outlier
Step 4: If it is above the median, determine whether the rate (ratio) is above the 75th percentile.  At the 75th percentile, 
75% of the hospitals had lower rates (ratios) and 25% of the hospital had higher rates (ratios).  
Step 5: If the rate (ratio) is above the 75th percentile, determine whether it is above the 90th percentile.  If it is, then the 
rate (ratio) is an outlier which may indicate a problem.  
Determining whether your hospital’s rate or ratio is a LOW outlier
Step 6: If it is below the median, determine whether the rate (ratio) is below the 25th percentile.  At the 25th percentile, 
25% of the hospitals had lower rates (ratios) and 75% of the hospitals had higher rates (ratios).  
Step 7: If the rate (ratio) is below the 25th percentile, determine whether it is below the 10th percentile.  If it is, then it is 
a low outlier which may be due to underreporting of infections.  If the ratio is below the 10th percentile, it is a low 
outlier and may be due to infrequent and/or short duration of device use.  
Note: Device-associated infection rates and device utilization ratios should be examined together so that preventive measures 
may be appropriately targeted.  For example, you find that the ventilator-associated pneumonia rate for a certain type of ICU 
is consistently above the 90th percentile and the ventilator utilization ratio is routinely between the 75th and 90th percen-
tile.  Since the ventilator is a significant risk factor for pneumonia, you may want to limit the duration of ventilation whenever 
possible (i.e., decrease unnecessary use) while at the same time optimize infection prevention strategies in patients for which 
ventilator use is required.
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